The analysis of the chemokines evaluated only showed a relationship with tumor differentiation; in the case of MCP-1, 40.7% of patients with low levels presented partially differentiated tumors with a significant association (p = 0.027); similarly, 33.3% of patients with partially differentiated tumors had low levels of IL-8. The gene discussed is CCL2; the disease is neoplasm.